
Atul Prafulla Patil
About Atul Prafulla Patil
Data last updated:
Atul Prafulla Patil is a Director at Gracious Pharmaceuticals Private Limited (since 2018), Director at Ravim Biotech Private Limited (since 2023) and Designated Partner at Praj Lifescience Llp (since 2017). The companies operate in Pharma, Chemicals and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹20.73 Cr; the largest is Gracious Pharmaceuticals Private Limited at ₹16.36 Cr (FY 2024). Earlier, Atul Prafulla Patil was a Designated Partner at Onkos Medicare Llp (2015–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Sep 2018 | 2018 | ₹16.36 Cr (FY 2024) | Active | |
| Director | 22 Dec 2023 | 2020 | ₹3.31 Cr (FY 2025) | Active | |
| Designated Partner | 20 Jun 2017 | 2017 | ₹1.05 Cr (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 17 Dec 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Atul Prafulla Patil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nidhi | 10437866 | Gracious Pharmaceuticals Private Limited , Ravim Biotech Private Limited | Director |
| Pramod Kumar Bharti | 07341497 | Gracious Pharmaceuticals Private Limited , Ravim Biotech Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Atul Prafulla Patil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atul Prafulla Patil
Atul Prafulla Patil currently holds 3 directorships: Gracious Pharmaceuticals Private Limited (Director, since 20 Sep 2018, revenue ₹16.36 Cr (FY 2024)); Ravim Biotech Private Limited (Director, since 22 Dec 2023, revenue ₹3.31 Cr (FY 2025)); Praj Lifescience Llp (Designated Partner, since 20 Jun 2017, revenue ₹1.05 Cr (FY 2022)).
Atul Prafulla Patil was first appointed on 17 Dec 2015 as Designated Partner at Onkos Medicare Llp. The most recent appointment on record is 22 Dec 2023 at Ravim Biotech Private Limited.
The 3 current companies of Atul Prafulla Patil that report revenue have a combined latest revenue of ₹20.73 Cr: Gracious Pharmaceuticals Private Limited ₹16.36 Cr (FY 2024); Ravim Biotech Private Limited ₹3.31 Cr (FY 2025); Praj Lifescience Llp ₹1.05 Cr (FY 2022).
Atul Prafulla Patil held 1 earlier board appointment: Onkos Medicare Llp (Designated Partner, 17 Dec 2015 to 31 Dec 2017).
The current boards of Atul Prafulla Patil's companies include Nidhi (Gracious Pharmaceuticals Private Limited), Pramod Kumar Bharti (Gracious Pharmaceuticals Private Limited).